SEVGLO 400 contains Sevelamer 400 mg, indicated for the treatment of hyperphosphatemia (increased phosphate levels in the blood) in patients with chronic kidney disease who are on dialysis. Maintaining normal phosphate levels is crucial in preventing bone disorders and cardiovascular complications associated with kidney failure. Sevelamer works by binding dietary phosphate in the gastrointestinal tract, thereby preventing its absorption into the bloodstream. This action helps lower serum phosphate levels effectively without increasing calcium levels, making it a preferred choice in long-term phosphate control for dialysis patients.
Sevelamer 400 mg binds phosphate in the intestine, reducing its absorption and effectively lowering blood phosphate levels in patients with kidney disease.
Controls High Phosphate Levels
Helps reduce elevated serum phosphate in dialysis patients.
Supports Bone Health
Prevents complications related to phosphate imbalance.
Non-Calcium Phosphate Binder
Does not increase calcium load in the body.
Essential in Dialysis Care
Plays a key role in managing mineral balance in kidney disease.
Suitable for Long-Term Use
Can be used chronically under medical supervision.
Take the tablet exactly as prescribed by a healthcare professional. It is usually taken with meals to maximize phosphate binding.
May include nausea, vomiting, constipation, abdominal pain, or indigestion. Seek medical advice if symptoms persist or worsen.
Globus Labs brings you WHO-GMP–certified, high-quality Sevelamer Tablets sourced from reputed pharmaceutical manufacturers. SEVGLO 400 is formulated to deliver safe, potent, and clinically trusted support.
Whether you’re seeking a franchise opportunity, exploring wholesale distribution, or evaluating Globus Labs for international trade, we’re here to help you build a strong, profitable partnership. Let’s discuss how we can grow together and create meaningful value for your business.